Venture Capital

Updated:

Fletcher Spaght Ventures

Fletcher Spaght, Inc. is a growth focused strategy consulting and transaction advisory firm accelerating growth for healthcare and life science companies...

Fletcher Spaght Ventures logo

Fletcher Spaght Ventures

Fletcher Spaght, Inc. is a growth focused strategy consulting and transaction advisory firm accelerating growth for healthcare and life science companies and their investors

General information

Firm type

Venture Capital

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Boston

Corporate office

Boston, MA, United States

Principals

Renard Charity

Managing Partner

Sector focus

MedTechDigital HealthLife Sciences Tools & DiagnosticsBiopharma & CROHealthcare Services

Frequently asked questions

Who runs investment decisions at Fletcher Spaght Ventures?

Renard Charity is the Managing Partner of Fletcher Spaght Ventures and leads its investment activity. The firm's senior team includes partners from the parent consulting firm, Fletcher Spaght, Inc., who bring operating and board-level experience in healthcare. John Fletcher, the co-founder, remains involved as Managing Partner Emeritus.

How does Fletcher Spaght Ventures source proprietary deal flow?

FSV sources deal flow primarily through its parent company, Fletcher Spaght, Inc., a healthcare growth-strategy consulting firm. The consulting practice engages with healthcare and life sciences companies on strategy, business planning, and transaction advisory, giving the investment team early visibility into emerging commercial traction and potential carve-outs that financial sponsors typically see only through formal processes.

Is Fletcher Spaght Ventures structured as a single family office or does it operate more like a venture firm?

It operates as a venture and growth-equity firm. It raised two blind-pool funds—FSV I at $30 million and FSV II at $100 million—rather than serving as a single-family office or investing off a balance sheet. The capital is presumably sourced from institutional and qualified individual investors, though the firm has not publicly named its limited partners.

What investment stages does Fletcher Spaght Ventures typically target?

FSV invests from seed-stage through growth and expansion rounds. It also pursues divestiture opportunities—buying corporate carve-outs or non-core divisions—leveraging the consulting firm's relationships with large healthcare corporates to source these transactions.

Which sectors does Fletcher Spaght Ventures explicitly avoid?

FSI's leadership states a primary focus on serving healthcare and life sciences clients, and FSV's second fund was raised specifically as a $100 million healthcare fund. There is no public indication that the firm invests in sectors outside of healthcare, such as general enterprise software, consumer technology, or industrial sectors.

How is Fletcher Spaght Ventures related to Fletcher Spaght, Inc.?

Fletcher Spaght Ventures is the investment arm of Fletcher Spaght, Inc., a Boston-based growth-strategy consulting firm founded in 1983. The consulting firm provides the deal origination, due-diligence capabilities, and market expertise that FSV leverages. The two entities share leadership, and the advisory business remains the core operating entity.

What is Fletcher Spaght Ventures' known posture on co-investments alongside external GPs?

FSV has not publicly described a co-investment program alongside external general partners. The firm is positioned as a direct investor making primary fund investments from its two dedicated vehicles, and its deal flow is anchored in the parent consultancy's work rather than syndicate-driven co-investing.

Does Fletcher Spaght Ventures maintain philanthropic structures, and how are they separated?

There are no publicly disclosed philanthropic foundations or donor-advised funds associated with Fletcher Spaght Ventures or its parent. The firm's sole known structure is a for-profit investment management entity operating alongside the consultancy.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Boston Venture Capital profiles